News

Filter

Current filters:

Astellas PharmaUMN Pharma

In Japan, Celgene’s Revlimid gets approval; Astellas to file degarelix and inks vaccine deal with UMN

23-08-2010

US drugmaker Celgene (Nasdaq: CELG) has been granted full marketing authorization by Japan’s Ministry…

Asia-PacificAstellas PharmaCelgenedegarelixLicensingOncologyPharmaceuticalRegulationRespiratory and PulmonaryRevlimidUMN PharmaVaccines

COMPANY SPOTLIGHT

Menarini

Back to top